Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects.

Frankle WG, Cho RY, Narendran R, Mason NS, Vora S, Litschge M, Price JC, Lewis DA, Mathis CA.

Neuropsychopharmacology. 2009 Feb;34(3):624-33. doi: 10.1038/npp.2008.104. Epub 2008 Jul 9.

2.

[11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levels.

Frankle WG, Cho RY, Mason NS, Chen CM, Himes M, Walker C, Lewis DA, Mathis CA, Narendran R.

PLoS One. 2012;7(2):e32443. doi: 10.1371/journal.pone.0032443. Epub 2012 Feb 27.

3.

In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients.

Frankle WG, Cho RY, Prasad KM, Mason NS, Paris J, Himes ML, Walker C, Lewis DA, Narendran R.

Am J Psychiatry. 2015 Nov 1;172(11):1148-59. doi: 10.1176/appi.ajp.2015.14081031. Epub 2015 Jul 2.

4.

Tiagabine does not attenuate alcohol-induced activation of the human reward system.

Fehr C, Hohmann N, Gründer G, Dielentheis TF, Buchholz HG, Chechko N, Yakushev I, Landvogt C, Bartenstein P, Urban R, Schreckenberger M.

Psychopharmacology (Berl). 2007 May;191(4):975-83. Epub 2007 Jan 30.

PMID:
17265078
5.

Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results.

Klumpers UM, Veltman DJ, Drent ML, Boellaard R, Comans EF, Meynen G, Lammertsma AA, Hoogendijk WJ.

Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):565-74. doi: 10.1007/s00259-009-1292-9. Epub 2009 Nov 5.

PMID:
19890631
6.

Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study.

Richardson MP, Koepp MJ, Brooks DJ, Fish DR, Duncan JS.

Ann Neurol. 1996 Aug;40(2):188-98.

PMID:
8773600
7.

GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study.

Lingford-Hughes AR, Wilson SJ, Cunningham VJ, Feeney A, Stevenson B, Brooks DJ, Nutt DJ.

Psychopharmacology (Berl). 2005 Aug;180(4):595-606. Epub 2005 Apr 28.

PMID:
15864554
8.

Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency.

Pearl PL, Gibson KM, Quezado Z, Dustin I, Taylor J, Trzcinski S, Schreiber J, Forester K, Reeves-Tyer P, Liew C, Shamim S, Herscovitch P, Carson R, Butman J, Jakobs C, Theodore W.

Neurology. 2009 Aug 11;73(6):423-9. doi: 10.1212/WNL.0b013e3181b163a5.

9.

Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia.

Busatto GF, Pilowsky LS, Costa DC, Ell PJ, David AS, Lucey JV, Kerwin RW.

Am J Psychiatry. 1997 Jan;154(1):56-63. Erratum in: Am J Psychiatry 1997 May;154(5):722.

PMID:
8988959
10.

Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography.

Hasler G, Nugent AC, Carlson PJ, Carson RE, Geraci M, Drevets WC.

Arch Gen Psychiatry. 2008 Oct;65(10):1166-75. doi: 10.1001/archpsyc.65.10.1166.

PMID:
18838633
11.

11C-flumazenil positron emission tomography demonstrates reduction of both global and local cerebral benzodiazepine receptor binding in a patient with Stiff Person Syndrome.

Galldiks N, Thiel A, Haense C, Fink GR, Hilker R.

J Neurol. 2008 Sep;255(9):1361-4. doi: 10.1007/s00415-008-0920-9. Epub 2008 Jun 27.

PMID:
18574617
12.

Acute increases in synaptic GABA detectable in the living human brain: a [¹¹C]Ro15-4513 PET study.

Stokes PR, Myers JF, Kalk NJ, Watson BJ, Erritzoe D, Wilson SJ, Cunningham VJ, Riano Barros D, Hammers A, Turkheimer FE, Nutt DJ, Lingford-Hughes AR.

Neuroimage. 2014 Oct 1;99:158-65. doi: 10.1016/j.neuroimage.2014.05.035. Epub 2014 May 17.

PMID:
24844747
13.

Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.

Lingford-Hughes A, Hume SP, Feeney A, Hirani E, Osman S, Cunningham VJ, Pike VW, Brooks DJ, Nutt DJ.

J Cereb Blood Flow Metab. 2002 Jul;22(7):878-89.

PMID:
12142573
14.

Where in-vivo imaging meets cytoarchitectonics: the relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET.

la Fougère C, Grant S, Kostikov A, Schirrmacher R, Gravel P, Schipper HM, Reader A, Evans A, Thiel A.

Neuroimage. 2011 Jun 1;56(3):951-60. doi: 10.1016/j.neuroimage.2010.11.015. Epub 2010 Nov 10.

PMID:
21073964
15.

Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder.

Cameron OG, Huang GC, Nichols T, Koeppe RA, Minoshima S, Rose D, Frey KA.

Arch Gen Psychiatry. 2007 Jul;64(7):793-800.

PMID:
17606813
16.

Gamma oscillations in V1 are correlated with GABA(A) receptor density: A multi-modal MEG and Flumazenil-PET study.

Kujala J, Jung J, Bouvard S, Lecaignard F, Lothe A, Bouet R, Ciumas C, Ryvlin P, Jerbi K.

Sci Rep. 2015 Nov 17;5:16347. doi: 10.1038/srep16347.

17.

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.

Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ.

Arch Gen Psychiatry. 1998 Aug;55(8):715-20.

PMID:
9707382
18.

Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET.

Syvänen S, Labots M, Tagawa Y, Eriksson J, Windhorst AD, Lammertsma AA, de Lange EC, Voskuyl RA.

J Nucl Med. 2012 Dec;53(12):1974-83. doi: 10.2967/jnumed.112.104588. Epub 2012 Nov 9.

19.

Sevoflurane and propofol increase 11C-flumazenil binding to gamma-aminobutyric acidA receptors in humans.

Salmi E, Kaisti KK, Metsähonkala L, Oikonen V, Aalto S, Någren K, Hinkka S, Hietala J, Korpi ER, Scheinin H.

Anesth Analg. 2004 Nov;99(5):1420-6; table of contents.

PMID:
15502041

Supplemental Content

Support Center